Medical manufacturers with female directors act more quickly and frequently on recalls

March 31, 2020

BLOOMINGTON, Ind. -- Medical product companies, such as those that make pharmaceuticals and medical devices, make recall decisions quite differently as women are added to their board of directors, according to a new study by professors at four universities, including Indiana University.

In life-threatening situations when defective medical products may kill a consumer, companies with female directors issue recalls much more quickly. For less severe instances in which there is greater discretion in the recall decision, recalls occur more frequently for companies that have women on their boards.

Both of these findings point to a more socially conscious and responsive decision-making culture regarding product quality when women are on a company's board of directors.

The study, published in the journal Manufacturing & Service Operations Management, is believed to be the first examining how female board representation relates to operations management, specifically in the context of product recall decision-making.

"Our study shows that there is a difference in real and important safety outcomes for consumers, between firms that have women on their boards and those who do not," said George Ball, assistant professor of operations and decision technologies at the Indiana University Kelley School of Business.

Other authors on the study are Kaitlin Wowak, assistant professor in the Department of Information, Analytics and Operations at the University of Notre Dame's Mendoza College of Business; Corinne Post, professor of management at Lehigh University; and Dave Ketchen, the Harbert Eminent Scholar at Auburn University.

Firms with female directors announced recalls of products with the most serious, life-threatening defects 28 days earlier than at firms where the board was all-male. This equates to a 35 percent reduction in time between when such firms were first made aware of a defect and when the decision was made to recall the product.

The researchers also found that companies with female directors initiated recalls of product defects that are less severe and easier to hide from regulators 120 percent more often. These situations often involved packaging and labeling issues. This is equal to 12 more of these type of recalls per firm.

A year ago, California became the first state to require that all public companies headquartered in the state have at least one female director. The European Commission mandates that all companies based in Europe have at least 40 percent female representation on their boards.

Previous research has suggested that women, compared to men, are more risk-averse, follow rules more closely and consider how their decisions influence a wider array of stakeholders.

While the addition of just one female director changed how recall decisions were made compared to firms with an all-male board, recall decisions continue to change as each additional woman is added to the board. Severe recalls are recalled more quickly, and discretionary low-severity recalls occur more often, as each additional female director was added.

The study relied on recall data obtained via a Freedom of Information Act request and recall timing data provided by the Food and Drug Administration. Researchers analyzed 4,271 medical product recalls from 2002 to 2013 across 92 publicly traded medical product firms regulated by the FDA.

Indiana University

Related Medical Devices Articles from Brightsurf:

Wearable pressure-sensitive devices for medical use
Novel design and strategic use of materials in a pressure-sensitive adhesive strip.

Researchers discover cyber vulnerabilities affecting bluetooth based medical devices
The Greyhound framework, named after the breed of dogs known for their hunting abilities, was designed and implemented by an SUTD-led research team to systematically sniff out security lapses in Wi-Fi and Bluetooth enabled devices.

Tiny devices promise new horizon for security screening and medical imaging
Miniature devices that could be developed into safe, high-resolution imaging technology, with uses such as helping doctors identify potentially deadly cancers and treat them early, have been created in research involving the University of Strathclyde.

Graphite nanoplatelets on medical devices kill bacteria and prevent infections
Graphite nanoplatelets integrated into plastic medical surfaces can prevent infections, killing 99.99 per cent of bacteria which try to attach -- a cheap and viable potential solution to a problem which affects millions, costs huge amounts of time and money, and accelerates antibiotic resistance.

Predicting the degradation behavior of advanced medical devices
Polymer materials play a vital role in today's medicine. While many applications demand for long-lasting devices, others benefit from materials that disintegrate once their job is done.

Ingestible medical devices can be broken down with light
MIT engineers have developed a light-sensitive material that allows gastrointestinal devices to be triggered to break down inside the body when they are exposed to light from an ingestible LED.

Fighting bacterial infection with drug-eluting medical devices
Medical practitioners routinely outfit patients with devices ranging from cardiovascular stents, pacemakers, catheters, and therapeutic lenses to orthopedic, breast, dental, and cochlear implants and prostheses.

Concerns over regulation of oral powders or gels sold as medical devices in Europe
Oral powders or gels, sold as medical devices in the European Union (EU), aren't regulated to the same safety standards as those applied to medicines, reveals research published online in the Archives of Disease in Childhood.

Cotton-based hybrid biofuel cell could power implantable medical devices
A glucose-powered biofuel cell that uses electrodes made from cotton fiber could someday help power implantable medical devices such as pacemakers and sensors.

How unsecured medical record systems and medical devices put patient lives at risk
A team of physicians and computer scientists at the University of California has shown it is easy to modify medical test results remotely by attacking the connection between hospital laboratory devices and medical record systems.

Read More: Medical Devices News and Medical Devices Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to